Abstract
Polyclonal anti-CN antibodies are used for the serotyping of CN clinical isolates and the diagnosis of cryptococcosis. They contribute to the characterization of CN capsular components. Many in vitro studies suggest that anti-CN antibodies, essentially IgG, could, if present, participate in yeast killing in vivo (T.R. Kozel, J.L. Follette, 1981, Infect. Immun., 31:978). However, previous attempts to protect mice against experimental cryptococcosis by passively transferred immune sera led to rather negative results. We report the production and characterization of a monoclonal mouse anti-CNPS antibody and evaluate its protective effect against experimental murine cryptococcosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
